HSPA4 and melanoma: Our results show that this compound also inhibits the intracellular chaperone activity of the Hsp70 system, and thus point to Hsp70 as an alternative target of PB that could be, at least in part, responsible for its marked toxicity against two melanoma cell lines without compromising the viability of fibroblast and primary melanocytes.